Zauatbayeva, G. .; Syzdykova , L.; Keyer , V. .; Shustov , A.; Abilmagzhanov , A.; Zhurynov , M. NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS. Eurasian Journal of Applied Biotechnology 2022, 44-53.